Efficacy and Safety of Autologous Hematopoietic Stem Cell Transplantation in Treating Type 1 Diabetes Mellitus
December 2010
in “
Zhonghua neifenmi daixie zazhi
”
Studysummary This study found that autologous nonmyeloablative hematopoietic stem cell transplantation may help some newly-onset type 1 diabetes patients become insulin-free, although gastrointestinal and other mild side effects were observed.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on rs.yiigle.com →